A joint model for nonlinear longitudinal data with informative dropout

被引:83
作者
Hu, CP [1 ]
Sale, ME [1 ]
机构
[1] GlaxoSmithKline, Res Modeling & Simulat, Res Triangle Pk, NC 27709 USA
关键词
nonlinear models; population modeling; mixed effects; missing data;
D O I
10.1023/A:1023249510224
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Subject withdrawal from a study (also called dropout, or right censoring), is common in late phase clinical trials. A number of methods dealing with dropouts have been used in practice, the most common being "last observation carried forward'' (LOCF). Many of these methods, including LOCF, can result in biased estimates of the efficacy or potency of the drug, especially in the modeling context. If the likelihood of dropout is correlated to the underlying unobserved data, the dropout is informative and should not be ignored in the modeling process. The topic of informative dropout in the context of longitudinal data has received much attention in the statistical literature, in the setting of linear and generalized linear models. We extend the approach to nonlinear models. The dropout hazard, as well as the longitudinal data, is modeled parametrically. Parameters are estimated by maximizing the approximate joint likelihood as implemented in the software NONMEM. Using data from actual clinical trials, we explore the impact of the dropout model on the ability of the joint model to predict observed longitudinal data patterns.
引用
收藏
页码:83 / 103
页数:21
相关论文
共 16 条
[1]  
BEAL SL, 1992, NONMEM USERS GUIDE
[2]   Coping with missing data in clinical trials: A model-based approach applied to asthma trials [J].
Carpenter, J ;
Pocock, S ;
Lamm, CJ .
STATISTICS IN MEDICINE, 2002, 21 (08) :1043-1066
[3]  
Diggle P. G., 1994, J ROY STAT SOC C, V43, P49
[4]  
Hogan JW, 1997, STAT MED, V16, P259
[5]   More efficient clinical trials through use of scientific model-based statistical tests [J].
Jonsson, EN ;
Sheiner, LB .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (06) :603-614
[6]  
KLEIN JP, 1997, SURVIVAL ANAL
[7]  
Little Roderick J.A., 2019, Statistical analysis with missing data, V793, DOI DOI 10.1002
[8]   Population pharmacodynamic model for ketorolac analgesia [J].
Mandema, JW ;
Stanski, DR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (06) :619-635
[9]  
RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
[10]   Characteristics of indirect pharmacodynamic models and applications to clinical drug responses [J].
Sharma, A ;
Jusko, WJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (03) :229-239